Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
A look at what the law says about buying prescription drugs from Canada.
Insurance companies can no longer implement harmful co-pay accumulator policies.
In fact, antiviral drugs account for nearly 14 percent of total drug costs in the program.
Stop me if you’ve heard this one before.
A look at the 2019 State of the Union address
Louisiana health officials are adopting the country’s first subscription model for hep C cures.
Older drugs, many on the market for years, are rising in cost much faster than inflation.
A new study examines the clinical and economic impact of new direct-acting antivirals.
New recommendations in the Annals of Internal Medicine would increase access to treatment.
60 groups sign a letter to state insurance commissioners and attorneys general asking them to reverse the policy.
Stocks of drug companies are rising—and that’s not a good sign for consumers.
He’ll oversee the FDA, Medicare and Medicaid at a time when soaring drug prices remain a contentious political topic.
U.S. lawmakers say appointing Azar is like putting “the pharmaceutical fox in charge of the health care henhouse.”
The state’s health secretary considers a radical plan to get the U.S. government to step in and override HCV patent protections.
Nearly a quarter of Americans say they have trouble paying for medications.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.